| Dr Johnny Nigoghosian, DDS | |
|
251 Grand Ave, Monrovia, CA 91016-2359 | |
| (626) 429-9723 | |
| Not Available |
| Full Name | Dr Johnny Nigoghosian |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 251 Grand Ave, Monrovia, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821402538 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 63485 (California) | Primary |
| Entity Name | Nigoghosian & Nigoghosian Dds Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912452251 PECOS PAC ID: 0840621124 Enrollment ID: O20200521000697 |
News Archive
New research from Concordia's John Molson School of Business has found that cycling can help reduce stress and improve your work performance.
Seeking to ignite the next major breakthroughs to treat blood cancers, The Leukemia & Lymphoma Society (LLS), The Mark Foundation, and The Paul G. Allen Frontiers Group today announced more than $6.75 million awarded to nine of the most exceptional scientists in the field.
Unpaid family and friends who assist older people with disabilities by coordinating doctor appointments and managing medications are significantly more likely to experience emotional, physical and financial difficulties than caregivers who don't provide this type of support, new research finds.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that its MuGard partner in China, Rhei Pharmaceuticals HK Ltd., received regulatory and marketing approval for MuGard in China from the State Food and Drug Administration, or SFDA, to treat oral mucositis in cancer patients.
› Verified 1 days ago
| Entity Name | Nigoghosian Dental Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326501891 PECOS PAC ID: 6305267659 Enrollment ID: O20200522001013 |
News Archive
New research from Concordia's John Molson School of Business has found that cycling can help reduce stress and improve your work performance.
Seeking to ignite the next major breakthroughs to treat blood cancers, The Leukemia & Lymphoma Society (LLS), The Mark Foundation, and The Paul G. Allen Frontiers Group today announced more than $6.75 million awarded to nine of the most exceptional scientists in the field.
Unpaid family and friends who assist older people with disabilities by coordinating doctor appointments and managing medications are significantly more likely to experience emotional, physical and financial difficulties than caregivers who don't provide this type of support, new research finds.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that its MuGard partner in China, Rhei Pharmaceuticals HK Ltd., received regulatory and marketing approval for MuGard in China from the State Food and Drug Administration, or SFDA, to treat oral mucositis in cancer patients.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Johnny Nigoghosian, DDS 251 Grand Ave, Monrovia, CA 91016-2359 Ph: (626) 429-9723 | Dr Johnny Nigoghosian, DDS 251 Grand Ave, Monrovia, CA 91016-2359 Ph: (626) 429-9723 |
News Archive
New research from Concordia's John Molson School of Business has found that cycling can help reduce stress and improve your work performance.
Seeking to ignite the next major breakthroughs to treat blood cancers, The Leukemia & Lymphoma Society (LLS), The Mark Foundation, and The Paul G. Allen Frontiers Group today announced more than $6.75 million awarded to nine of the most exceptional scientists in the field.
Unpaid family and friends who assist older people with disabilities by coordinating doctor appointments and managing medications are significantly more likely to experience emotional, physical and financial difficulties than caregivers who don't provide this type of support, new research finds.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, announced that its MuGard partner in China, Rhei Pharmaceuticals HK Ltd., received regulatory and marketing approval for MuGard in China from the State Food and Drug Administration, or SFDA, to treat oral mucositis in cancer patients.
› Verified 1 days ago
Joseph Park, DDS Dentist Medicare: Medicare Enrolled Practice Location: 925 W Foothill Blvd Ste C, Monrovia, CA 91016 Phone: 626-408-0800 | |
Ivy X. Li, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 945 W Duarte Rd, Monrovia, CA 91016 Phone: 626-445-2178 | |
Dr. Haig Levon Gazarian, DMD, MA Dentist Medicare: Not Enrolled in Medicare Practice Location: 925 W Foothill Blvd Ste B, Monrovia, CA 91016 Phone: 626-873-1500 | |
Dr. Thomas P. Redican, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 686 W Foothill Blvd, Monrovia, CA 91016 Phone: 626-357-3281 Fax: 626-357-3282 | |
Dr. Christine Chu, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 626 S Primrose Ave, Monrovia, CA 91016 Phone: 626-775-5118 Fax: 626-509-8200 | |
Patrick Y Challita, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 717 W Foothill Blvd, Monrovia, CA 91016 Phone: 626-355-2211 | |
Dr. Paul Genino, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 858 W Foothill Blvd Ste E, Monrovia, CA 91016 Phone: 626-358-0178 |